D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 40 (11) , 1039-1044
- https://doi.org/10.1016/0024-3205(87)90565-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonistsEuropean Journal of Pharmacology, 1986
- Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivoEuropean Journal of Pharmacology, 1986
- Catalepsy induced by SCH 23390 in ratsEuropean Journal of Pharmacology, 1985
- SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylaseBrain Research, 1985
- SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphineEuropean Journal of Pharmacology, 1985
- Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonistLife Sciences, 1985
- 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brainEuropean Journal of Pharmacology, 1984
- SCH-23390: A selective D1 dopamine antagonist with potent D2 behavioral actionsEuropean Journal of Pharmacology, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- SCH 23390—The first selective dopamine D-1 antagonistEuropean Journal of Pharmacology, 1983